Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

by Pascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck, Catherine Guérin-Charbonnel, Hamza Lasla, Wilfried Gouraud, Jean-Luc Canon, Andrea Gombos, Florence Dalenc, Suzette Delaloge, Jérôme Lemonnier, Delphine Loussouarn, Véronique Verrièle, Mario Campone
Published 2019-05-01

Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasi...

by Jacques De Grève, Jan Van Meerbeeck, Johan F Vansteenkiste, Lore Decoster, Anne-Pascale Meert, Peter Vuylsteke, Christian Focan, Jean-Luc Canon, Yves Humblet, Guy Berchem, Benoit Colinet, Danny Galdermans, Lionel Bosquée, Joanna Vermeij, Alex Dewaele, Caroline Geers, Denis Schallier, Erik Teugels
Published 2016-01-01

Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families

by Cédric Van Marcke, Raphaël Helaers, Anne De Leener, Ahmad Merhi, Céline A. Schoonjans, Jérôme Ambroise, Christine Galant, Paul Delrée, Françoise Rothé, Isabelle Bar, Elsa Khoury, Pascal Brouillard, Jean-Luc Canon, Peter Vuylsteke, Jean-Pascal Machiels, Martine Berlière, Nisha Limaye, Miikka Vikkula, François P. Duhoux
Published 2020-04-01

Genomic Grade Index (GGI): feasibility in routine practice and impact on treatment decisions in early breast cancer.

by Otto Metzger-Filho, Aurélie Catteau, Stefan Michiels, Marc Buyse, Michail Ignatiadis, Kamal S Saini, Evandro de Azambuja, Virginie Fasolo, Sihem Naji, Jean Luc Canon, Paul Delrée, Michel Coibion, Pino Cusumano, Veronique Jossa, Jean Pierre Kains, Denis Larsimont, Vincent Richard, Daniel Faverly, Nathalie Cornez, Peter Vuylsteke, Brigitte Vanderschueren, Hélène Peyro-Saint-Paul, Martine Piccart, Christos Sotiriou
Published 2013-01-01